Hereditary angioedema
Clinical trials for Hereditary angioedema explained in plain language.
Never miss a new study
Get alerted when new Hereditary angioedema trials appear
Sign up with your email to follow new studies for Hereditary angioedema, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a simple pill shield HAE patients from Procedure-Triggered attacks?
Disease control Recruiting nowThis trial tests whether the drug sebetralstat can prevent swelling attacks in people with hereditary angioedema (HAE) when taken before a medical procedure. Participants aged 12 and older with HAE type I or II will take sebetralstat just before their scheduled procedure. The mai…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase 4 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
New RNA drug aims to stop debilitating swelling attacks in rare genetic condition
Disease control Recruiting nowThis phase 3 trial is testing an experimental drug called ADX-324 in 90 adults with hereditary angioedema (HAE) types 1 or 2. HAE causes sudden, painful swelling in the body. ADX-324 uses a technology called siRNA to lower levels of a protein involved in triggering these attacks.…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase 3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated Sep 12, 2026 00:00 UTC
-
New oral option may offer relief for hereditary angioedema attacks
Disease control Expanded accessThis program provides access to an experimental oral medication called deucrictibant for people with hereditary angioedema (HAE) who have no satisfactory alternative treatments for acute attacks. Eligible participants, aged 12 to 75, take the capsule as needed to manage swelling …
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: Pharvaris Netherlands B.V. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for kids with rare swelling disorder: early access drug offered
Disease control Expanded accessThis program provides early access to an investigational drug called sebetralstat for children aged 2 to 11 with hereditary angioedema (HAE), a condition causing sudden, painful swelling. The drug is taken at the start of an attack to reduce symptoms. It is available to children …
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information on people with rare diseases like amyloidosis, sarcoidosis, and Gaucher disease. Researchers will track patients' health over time, including their symptoms, treatments, and outcomes. The goal is to improve diagnosis …
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC